Literature DB >> 20922767

Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain.

Mar Fernandez de Marco1, Jacqueline Linehan, O Noel Gill, Jonathan P Clewley, Sebastian Brandner.   

Abstract

There have been 173 cases of variant Creutzfeldt-Jakob disease (vCJD) in the UK, as of 5 July 2010, as a result of the bovine spongiform encephalopathy epidemic. The number of individuals subclinically infected with vCJD, and thus the eventual number of cases, remains, however, uncertain. In an attempt to address this problem, 63,007 tonsil tissue specimens were previously tested by enzyme immunoassay (EIA) for the presence of disease-related prion protein (PrP(res)) and found to be negative. To confirm the reliability of this result, all those in the birth cohort most at risk (1961-1985) and a few others, including controls, have now been tested by immunohistochemistry (IHC). Histological slides were prepared from 10,075 anonymized formalin-fixed, paraffin-embedded tissues and examined for PrP(res) with two anti-prion protein antibodies, ICMS35 and KG9. One specimen showed a single strongly positive follicle with both antibodies, on two slides from adjacent sections. As this specimen was negative when it was further investigated by EIA, IHC, and immunoblotting, it is unclear whether the patient from whom the tonsil came will go on to develop vCJD. If, however, this is the case, then a finding of 1 out of 9160 gives a prevalence of disease-related prion protein in the British population of 109 per million, with a 95% confidence interval (CI) of 3-608 per million, which is not statistically different (exact p = 0.63) from population prevalence estimates based on finding three positives out of 10 278 in a previous IHC study of appendix tissue. If this is not the case, a finding of 0 out of 9160 gives a prevalence of 0-403 per million (95% CI) for the 1961-1985 cohort, which is also not different (exact p = 0.25) from previous population prevalence estimates. Therefore, the results of this work could be summarized as finding, by IHC, no or one vCJD-positive individual.
Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20922767     DOI: 10.1002/path.2767

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.

Authors:  Paula Saá; Oksana Yakovleva; Jorge de Castro; Irina Vasilyeva; Silvia H De Paoli; Jan Simak; Larisa Cervenakova
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

2.  Could immunomodulation be used to prevent prion diseases?

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Anti Infect Ther       Date:  2012-03       Impact factor: 5.091

3.  Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling review.

Authors:  Matt Stevenson; Lesley Uttley; Jeremy E Oakley; Christopher Carroll; Stephen E Chick; Ruth Wong
Journal:  Health Technol Assess       Date:  2020-02       Impact factor: 4.014

Review 4.  Non-human primates in prion diseases.

Authors:  Emmanuel E Comoy; Jacqueline Mikol; Jean-Philippe Deslys
Journal:  Cell Tissue Res       Date:  2022-06-04       Impact factor: 5.249

Review 5.  Prion Diseases.

Authors:  Michael D Geschwind
Journal:  Continuum (Minneap Minn)       Date:  2015-12

6.  The effects of host age on the transport of complement-bound complexes to the spleen and the pathogenesis of intravenous scrapie infection.

Authors:  Karen L Brown; Anton Gossner; Simon Mok; Neil A Mabbott
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

7.  The molecular epidemiology of variant CJD.

Authors:  Graham A Mackay; Richard Sg Knight; James W Ironside
Journal:  Int J Mol Epidemiol Genet       Date:  2011-06-03

Review 8.  Laboratory activities involving transmissible spongiform encephalopathy causing agents: risk assessment and biosafety recommendations in Belgium.

Authors:  Amaya Leunda; Bernadette Van Vaerenbergh; Aline Baldo; Stefan Roels; Philippe Herman
Journal:  Prion       Date:  2013-09-20       Impact factor: 3.931

9.  Prion protein-specific antibodies that detect multiple TSE agents with high sensitivity.

Authors:  Sandra McCutcheon; Jan P M Langeveld; Boon Chin Tan; Andrew C Gill; Christopher de Wolf; Stuart Martin; Lorenzo Gonzalez; James Alibhai; A Richard Alejo Blanco; Lauren Campbell; Nora Hunter; E Fiona Houston
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

10.  Foodborne transmission of bovine spongiform encephalopathy to nonhuman primates.

Authors:  Edgar Holznagel; Barbara Yutzy; Walter Schulz-Schaeffer; Carina Kruip; Uwe Hahmann; Pär Bierke; Juan-Maria Torres; Yong-Sun Kim; Achim Thomzig; Michael Beekes; Gerhard Hunsmann; Johannes Loewer
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.